Search Results - "Kai, Marc P."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    PEGylated PRINT Nanoparticles: The Impact of PEG Density on Protein Binding, Macrophage Association, Biodistribution, and Pharmacokinetics by Perry, Jillian L, Reuter, Kevin G, Kai, Marc P, Herlihy, Kevin P, Jones, Stephen W, Luft, J. Chris, Napier, Mary, Bear, James E, DeSimone, Joseph M

    Published in Nano letters (10-10-2012)
    “…In this account, we varied PEGylation density on the surface of hydrogel PRINT nanoparticles and systematically observed the effects on protein adsorption,…”
    Get full text
    Journal Article
  2. 2

    Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells by Fromen, Catherine A., PhD, Rahhal, Tojan B., BS, Robbins, Gregory R., PhD, Kai, Marc P., PhD, Shen, Tammy W., PhD, Luft, J. Christopher, PhD, DeSimone, Joseph M., PhD

    Published in Nanomedicine (01-04-2016)
    “…Abstract Engineered nanoparticles have the potential to expand the breadth of pulmonary therapeutics, especially as respiratory vaccines. Notably, cationic…”
    Get full text
    Journal Article
  3. 3

    Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization by Fromen, Catherine A., Robbins, Gregory R., Shen, Tammy W., Kai, Marc P., Ting, Jenny P. Y., DeSimone, Joseph M.

    “…Significance To our knowledge, no other nano-based vaccine delivery platform has directly assessed the effects of nanoparticle charge on pulmonary vaccination…”
    Get full text
    Journal Article
  4. 4

    Nanoparticle clearance is governed by Th1/Th2 immunity and strain background by Jones, Stephen W, Roberts, Reid A, Robbins, Gregory R, Perry, Jillian L, Kai, Marc P, Chen, Kai, Bo, Tao, Napier, Mary E, Ting, Jenny P Y, Desimone, Joseph M, Bear, James E

    Published in The Journal of clinical investigation (01-07-2013)
    “…Extended circulation of nanoparticles in blood is essential for most clinical applications. Nanoparticles are rapidly cleared by cells of the mononuclear…”
    Get full text
    Journal Article
  5. 5

    Biodistribution and Toxicity of Micellar Platinum Nanoparticles in Mice via Intravenous Administration by Brown, Anna L, Kai, Marc P, DuRoss, Allison N, Sahay, Gaurav, Sun, Conroy

    Published in Nanomaterials (Basel, Switzerland) (07-06-2018)
    “…Platinum nanoparticles (PtNPs) have shown promise as diagnostic and therapeutic agents due to their unique physiochemical properties. However, critical…”
    Get full text
    Journal Article
  6. 6

    Tumor Presence Induces Global Immune Changes and Enhances Nanoparticle Clearance by Kai, Marc P, Brighton, Hailey E, Fromen, Catherine A, Shen, Tammy W, Luft, J. Christopher, Luft, Yancey E, Keeler, Amanda W, Robbins, Gregory R, Ting, Jenny P. Y, Zamboni, William C, Bear, James E, DeSimone, Joseph M

    Published in ACS nano (26-01-2016)
    “…Long-circulating nanoparticles are essential for increasing tumor accumulation to provide therapeutic efficacy. While it is known that tumor presence can alter…”
    Get full text
    Journal Article
  7. 7

    Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery by Shen, Tammy W., Fromen, Catherine A., Kai, Marc P., Luft, J. Christopher, Rahhal, Tojan B., Robbins, Gregory R., DeSimone, Joseph M.

    Published in Pharmaceutical research (01-10-2015)
    “…Purpose We evaluated the role of a poly(ethylene glycol) (PEG) surface coating to increase residence times and alter the cellular fate of nano- and…”
    Get full text
    Journal Article
  8. 8

    Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle by Kai, Marc P., Keeler, Amanda W., Perry, Jillian L., Reuter, Kevin G., Luft, J. Christopher, O'Neal, Sara K., Zamboni, William C., DeSimone, Joseph M.

    Published in Journal of controlled release (28-04-2015)
    “…Cisplatin is a cytotoxic drug used as a first-line therapy for a wide variety of cancers. However, significant renal and neurological toxicities limit its…”
    Get full text
    Journal Article
  9. 9

    Pulmonary Delivery of Butyrylcholinesterase as a Model Protein to the Lung by Rahhal, Tojan B, Fromen, Catherine A, Wilson, Erin M, Kai, Marc P, Shen, Tammy W, Luft, J. Christopher, DeSimone, Joseph M

    Published in Molecular pharmaceutics (02-05-2016)
    “…Pulmonary delivery has great potential for delivering biologics to the lung if the challenges of maintaining activity, stability, and ideal aerosol…”
    Get full text
    Journal Article
  10. 10

    Calibration-quality cancer nanotherapeutics by Perry, Jillian L, Kai, Marc P, Reuter, Kevin G, Bowerman, Charles, Christopher Luft, J, DeSimone, Joseph M

    Published in Cancer treatment and research (2015)
    “…Nanoparticle properties such as size, shape, deformability, and surface chemistry all play a role in nanomedicine drug delivery in cancer. While many studies…”
    Get more information
    Journal Article